EUVIMEDEUVIMED entdecken
Vergleichsstudie

Assessing EPO stability in urine and comparing recombinant EPO detectability in matched urine, venous serum, and capillary serum following a controlled epoetin alfa administration

Geoffrey D Miller iD, Jenna M Goodrum iD, Andre K Crouch, Daniel Eichner

Drug Testing and Analysis · 2025

DOI: 10.1002/dta.3736 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Geoffrey D Miller und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sports Medicine Research and Testing Laboratory, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Substance Abuse Detection, Erythropoietin, Epoetin Alfa. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 11 Literaturangaben. Gefördert von: Sports Medicine Research and Testing Laboratory, World Anti-Doping Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The instability of erythropoietin receptor agonists (ERAs, i.e., EPO) in urine presents a challenge to their detectability in doping control samples; however, this issue is not often seen in blood (serum) samples. With the anti‐doping field beginning to transition into alternative blood collection technologies, it is important to understand recombinant EPO (rEPO) detectability in serum samples collected from one such capillary collection device, the Tasso+ SST. Twelve individuals were administered a single, 40 IU/kg dose of rEPO (epoetin alfa, EPOGEN®). Following administration, matched urine, venous serum, and capillary serum samples were concurrently collected. Urine aliquots were subject to various storage times and temperatures mimicking shipping conditions of doping control urine samples to assess EPO stability, while other urine aliquots, venous serum, and capillary serum aliquots were frozen until analysis to understand rEPO detectability across all three matrices. EPO and rEPO instability was identified in urine collected from 8 of 12 participants, especially in aliquots stored at room temperature and 37°C. In some of these unstable samples, rEPO was still detectable, while in others, no recombinant nor endogenous EPO was detectable and would have resulted in negative sample reports. Analyzing the concurrently collected urine, venous, and capillary serum samples, rEPO detectability was identical across the three matrices. In most cases, rEPO was detectable for at least 168 h post‐administration. Noting greater stability in blood compared with urine, it is recommended that anti‐doping authorities utilize this novel capillary serum collection technology to improve overall ERA detectability in doping control samples.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance Abuse DetectionErythropoietinEpoetin AlfaHumansDoping in SportsMaleRecombinant ProteinsAdultFemaleYoung AdultDrug StabilityBlood Specimen Collection

Stichwörter der Autor:innen

EPOTassoanti‐dopingcapillary blood

Substanzen

ErythropoietinEpoetin AlfaRecombinant Proteins

Autor:innen und Institutionen

  • Sports Medicine Research and Testing Laboratory, Salt Lake City, Utah, USA.

ORCID-Profile: Geoffrey D Miller, Jenna M Goodrum

Förderung

  • Sports Medicine Research and Testing Laboratory
  • World Anti-Doping Agency

Zitieren

APA

Miller, G. D., Goodrum, J. M., Crouch, A. K., & Eichner, D. (2025). Assessing EPO stability in urine and comparing recombinant EPO detectability in matched urine, venous serum, and capillary serum following a controlled epoetin alfa administration. Drug Testing and Analysis. https://doi.org/10.1002/dta.3736

Vancouver

Miller GD, Goodrum JM, Crouch AK, Eichner D. Assessing EPO stability in urine and comparing recombinant EPO detectability in matched urine, venous serum, and capillary serum following a controlled epoetin alfa administration. Drug Testing and Analysis. 2025. doi:10.1002/dta.3736

BibTeX
@article{Miller2025,
  author = {Miller, Geoffrey D and Goodrum, Jenna M and Crouch, Andre K and Eichner, Daniel},
  title = {Assessing EPO stability in urine and comparing recombinant EPO detectability in matched urine, venous serum, and capillary serum following a controlled epoetin alfa administration},
  journal = {Drug Testing and Analysis},
  year = {2025},
  doi = {10.1002/dta.3736}
}
Kostenlos starten →